Primacy of surgery for colorectal cancer
Authors:
Open Access
- 2 April 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 102 (7) , 847-852
Abstract
Background: The optimal technique for curative resection of colonic cancer includes high ligation of the mesenteric vessels, wide excision of the colonic mesentery and prevention of tumour cell spillage. This article reports results from the authors' institution for patients in whom complete mesocolic excision was performed long before the term was coined. Methods: Patients operated on for cure for primary adenocarcinoma of the colon between January 1994 and December 2004 were identified from a prospectively maintained, institutional review board-approved, colorectal cancer registry. Medical records and operation notes were reviewed. The primary outcomes were recurrence (local and distal) and age-adjusted 5-year survival. Results: Some 1013 patients (560 men and 453 women) were identified, with a median age of 69 (range 21–96) years. The most common location of the cancer was the sigmoid colon (32·9 per cent), followed by the caecum (26·7 per cent) and ascending colon (17·0 per cent). Operations were performed laparoscopically in 134 patients (13·2 per cent). Median duration of hospital stay was 7 (range 1–64, mean 8·2) days. Overall morbidity and mortality rates were 13·5 and 2·2 per cent respectively; there were 20 anastomotic leaks (2·0 per cent). Some 282 patients (27·8 per cent) had stage I, 386 (38·1 per cent) stage II and 345 (34·1 per cent) stage III disease. Median lymph node yield was 28·3 (range 0–241, mean 28·3), and 12 or more nodes were examined in 88·1 per cent of patients. Adjuvant chemotherapy was administered to 277 patients (80·3 per cent) with stage III disease. Overall local and distant recurrence rates at 5 years were 5·1 and 17·1 per cent respectively. The 5-year local recurrence rate was 2·2, 5·3 and 7·7 per cent for American Joint Committee on Cancer stages I, II and III respectively. Corresponding distant recurrence rates were 4·0, 14·7 and 30·5 per cent. The 5-year overall cancer-free age-standardized survival rate was 85·3 per cent. Five-year age standardized survival rates for patients with disease stages I, II and III were 97·7, 90·8 and 69·8 per cent respectively. Conclusion: These data define modern results of surgery for colonic cancer with conservative use of chemotherapy.Keywords
This publication has 18 references indexed in Scilit:
- Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcomeColorectal Disease, 2009
- Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group TrialAnnals of Surgery, 2007
- Loco-regional Recurrence from Colon Cancer: A Population-based StudyAnnals of Surgical Oncology, 2006
- Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined populationBritish Journal of Surgery, 2006
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004
- The Prognosis of T3N0 Colon Cancer Is Dependent on the Number of Lymph Nodes ExaminedAnnals of Surgical Oncology, 2003
- Lymph Node Recoveries From 2427 pT3 Colorectal Resection Specimens Spanning 45 YearsAmerican Journal of Surgical Pathology, 2002
- No-Touch isolation technique in colon cancer: A controlled prospective trialBritish Journal of Surgery, 1988
- The No-Touch Isolation Technique of ResectionJAMA, 1975
- Cancer Of The ColonAnnals of Surgery, 1967